AARD

NASDAQ · Pharmaceuticals

Aardvark Therapeutics Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$7.90

+0.60 (+8.22%)

As of Aug 9, 10:32 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 11 61%

Hold 5 28%

Sell 2 11%

Price Target

Analyst Price Target +232.2% upside

Low Target $21.03

Average Target $26.24

High Target $41.18

Current Price $7.90

Current
$7.90

Target
$26.24

$21.03 $26.24 avg $41.18

Scenario Analysis

Bear Case

$21.03

166.2%

Low target

Base Case

$26.24

+232.2%

Avg target

Bull Case

$41.18

+421.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$17.94

-56.0% from high

52-Week Low

$3.35

+135.8% from low

Target vs 52W High

$26.24

+46.3% vs high

Next Earnings Report

Aug 19, 2026

until earnings

EPS Est: $-0.89

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%